Unihex Pharmaceuticals Private Limited
About Unihex Pharmaceuticals Private Limited
Data last updated:
Unihex Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 17 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51900TG2015PTC098508. Its GSTIN is 36AABCU8074A1ZG (Telangana).
The company has an authorised share capital of ₹1.2 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors Mohammad Javed Pasha and Hafiz Syed Rafiuddin Ahmed.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹10.96 Lakh, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹17,890 (net margin 1.6%) and EBITDA of ₹31,304 (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unihex Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 3 – 10 – 410/2 Plot No. 21 Bahadurguda Village Saroornagar Mandal Ghmc L.B.Nagar Circ, Le, Hyderabad, Telangana, India – 500074
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Unihex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unihex Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Unihex Pharmaceuticals Private Limited, buy the company report.
Financials of Unihex Pharmaceuticals Private Limited
FY 2022 filings availableUnihex Pharmaceuticals Private Limited reported revenue of ₹10.96 Lakh (up 45% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 45% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31,304 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17,890 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unihex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unihex Pharmaceuticals Private Limited
Unihex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Javed Pasha | Director | 17 Apr 2015 | 11 Years 6 Months | Current |
| Hafiz Syed Rafiuddin Ahmed | Director | 17 Apr 2015 | 11 Years 6 Months | Current |
Auditor
Unihex Pharmaceuticals Private Limited is audited by BANDARU SRINATH FCA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BANDARU SRINATH FCA | FY 2017 | 205638 |
Shareholding
The shareholding of Unihex Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unihex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unihex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unihex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unihex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCU8074A1ZG | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unihex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unihex Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Hafiz Syed Rafiuddin Ahmed was appointed as Director on 17 Apr 2015.
Frequently asked questions
Unihex Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in retail trading, within the trading industry. It was incorporated on 17 April 2015 (11+ years old) and is registered under CIN U51900TG2015PTC098508.
Unihex Pharmaceuticals has 2 current directors:
- Mohammad Javed Pasha - Director
- Hafiz Syed Rafiuddin Ahmed - Director
The latest financial statements of Unihex Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Unihex Pharmaceuticals is 36AABCU8074A1ZG, registered in Telangana.
The CIN (Corporate Identification Number) of Unihex Pharmaceuticals is U51900TG2015PTC098508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unihex Pharmaceuticals was incorporated on 17 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Hafiz Syed Rafiuddin Ahmed was appointed as Director on 17 Apr 2015. Mohammad Javed Pasha was appointed as Director on 17 Apr 2015.
The registered office of Unihex Pharmaceuticals is at H.No. 3 – 10 – 4102 Plot No. 21 Bahadurguda Village Saroornagar Mandal Ghmc L.B.Nagar Circ, Le, Hyderabad, Telangana, India – 500074.
Unihex Pharmaceuticals operates in the trading industry, in the retail trading segment.
The compliance status of Unihex Pharmaceuticals is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
